We naturally feel the need to have hair on our head. Scientists and companies take advantage of that specific need for profit as their only goal.
As it has been proved by valid scientific sources, several techniques and products that promise to solve hair loss and baldness are promoted by cosmetic companies and surgeons without imposing them in clinical trials to test their results and safety.
Cosmetic products are running on the market with specific ingredients that are accepted by the law making everyone capable of making a product that works “against hair loss” without any results or safety.
Likewise, PRP and MSC (Stem cells) methods are procedures that are being commercialized as treatments against hair loss among other diseases and health conditions without having been imposed to clinical trials, by surgeons with insubstantial allegations.
It appears to be a muscle toxic method and not a “natural treatment” by any chance, for anything. None proof for two methods that are being commercialized by surgeons for thousands of euros.
On the contrary to the above, Mr. Mexis’ invention, a cosmetic lotion, holds certificates of clinical trials of efficacy and safety and it is used by people for more than 25 years with absolute success.
More about stem cells
A cell can be considered as highly useful when all the human tissues – or a large part of them- can be derived by. Nevertheless, things aren’t that simple. In order for cells to be differentiated, a steam cells’ guiding procedure should be discovered.
Steam cells have the ability to get reproduced by themselves. They can create identical copies (clones) of themselves. The new steam cell can remain as stem cell or get differentiated in another cell type. For example, in skin cell, blood cell e.t.c.
Yet, steam cells, as far as the quality of their autonomous multiplication is concerned, they look a lot with cancer cells. Consequently, there is a question, after all, of how they can be controlled not to act like the cancer ones.
Striking scams for stem cell fraud
30.000 families who have paid for their children’s stem cells to be conserved for two decades got informed from the media that the company went bankrupt.Some executives of “STEM HEALTH HELLAS S.A.” (“ Ιατρική Τεχνολογική Ελληνική Τράπεζα Βλαστοκυττάρων Α.Ε”) after the severe criminal charges that brought against them by the Attorney General of Athens, they got accounted for cunning.
The prosecutions are also directed against the legal representatives of the Health Group, to which “Steam Health Hellas” belonged until 2013.
Taken from protothema.gr
The main problem is that there are no clinical studies of safety and efficacy for the specific methods yet.
Alopecia is determined mainly by genes. Therefore all we’re going to do is about maintenance of the remaining hair and slowing down the final result.
It is not possible for us to predict the amount of hair follicles that will be developed or ensure a uni-formal thickening or the new hair’s quality specifications. Also, no one can ensure that the new hair will follow a regular hair’s natural life circle or remain forever.
In addition, we have to mention that for the hair cloning to be approved in the future, it has to be completely safe. It is a mandatory need for clinical studies to search whether there’s a possibility for the cloned follicles to lead to the creation of cancerous tumors.
There are different prospects according to the exact timing that the follicle cloning will be a widespread technique with good results against hair loss.In August of 2012, Mr. Kotsarelis announced that he was making advanced discussions with pharmaceutical companies for the evolution of a treatment and as he declared, this treatment could be in the market any time in the following 2 year period.
The specific treatment would help men who are in the first stages of baldness only by slowing down only the thinning of the new hair.It is worth mentioning that under normal conditions, stem cells would create a healthy tissue. It is believed that genetic mistakes, in a possible combination with external causes, can make a stem cell or a subsidiary cell create defective cells.